gear Push settings
Our long-term fight against viruses continues — but we're getting new weapons.
Researchers are looking at proactive ways through which we can defend ourselves from viruses.
It's the same mRNA technology that was used in coronavirus vaccines.
It would greatly help our efforts to contain Lyme disease.
There are two approved monkeypox vaccines in the US. Both use a related poxvirus called vaccinia to produce an immune response that protects against smallpox and monkeypox.
The trial involves the most powerful human antibodies ever discovered.
Researchers have found that immune cells from a cold attack Covid differently from vaccines.
The annual flu shot might become a thing of the past.
This could help boost vaccination in lower-income countries where vaccine availability is problematic, while offering a reliable strategy.
It won't happen overnight, but an HIV vaccine could be on the way.
It's already saved thousands of women from cancer.
While the country may not reach full vaccination by the end of the year, it's definitely making progress.
Understanding how our immune responses vary over time is paramount to ending this pandemic.
"This is a historic moment," said WHO chief.
No jab, and more efficiency.
While this isn't ideal news, it would be much worse if we didn't know.
The next question is often, “Is there anything else that can be done?” Too often, the answer is no.
It only works for those who have a somewhat conspiracy mindset. Those with entrenched views are less likely to get the vaccine no matter what.
Those who had a flu shot were 20% less likely to end up in the ICU compared to patients who didn't get the jab.
The same technology used in mRNA COVID-19 vaccines could now help us fight cancer.
This is the kind of surprise I like.
A fake vaccination campaign designed to confirm Bin laden's location harmed legitimate vaccine programs in the country years later.
Most people don't experience side effects to the COVID vaccines. Here's why you shouldn't be particularly worried.
It's the first vaccine to meet the WHO efficacy goal.
Hopefully, future tests will support these findings.
It was safe and showed efficacy for 97% of the participants in the trial.
It's like open-source software now.
A novel vaccine seems to stop tumors from growing in the brain.
Things are encouraging, but there are also serious concerns.
Life could go back to normal this fall.
Drug manufacturers Pfizer and Moderna are ramping up production of their COVID-19 vaccine. Johnson & Johnson is waiting for approval for their one-shot vaccine. According to a statement presented to a House subcommittee earlier today, this could end up doubling, possibly tripling the vaccine supply in the US in the coming weeks. Last year, getting […]
Just 66 cases of anaphylaxis (0.0003%) were reported. All but one happened in the first 11 minutes. None were fatal.
Reasons to be optimistic as vaccine campaign rolls out: the Pfizer vaccine is really good.
You don't get a vaccine and become immune the next second. It usually takes a while -- and we're not sure how long it lasts.
Vaccination probably doesn't work the way you imagine it does.
It's the same mild shoulder pain you get from the flu shot or any other kind of vaccine.
Months after it started being administered, the Sputnik V vaccine was proven to be safe and effective.
It's not quite as effective as some other vaccines, but it only needs a single jab
Several vaccines have laid claim to the 'cheapest' title. Things aren't entirely clear, but some vaccines are definitely cheaper than others.
Both are mRNA vaccines -- the first of this type -- and are similar in many ways, but there are also some key differences.
It’s the fastest-developed vaccine ever -- here’s how we pulled it off.
We still don't know the full extent, but results seem encouraging for the Pfizer vaccine.
Researchers from Europe and the United States show that a new tuberculosis vaccine, MTBVAC, protects better than the current BCG vaccine in a model of tuberculosis in macaques.
It's not one year for a vaccine that's rushed -- it's the 'normal' ten years that's slow.
The vaccine offered "strong" and "durable" protection in early-stage clinical trials.
While you're living in 2020, Russia is already living in a risky 2021.
As the weather cools, the number of infections of the COVID-19 pandemic are rising sharply. Hamstrung by pandemic fatigue, economic constraints and political discord, public health officials have struggled to control the surging pandemic. But now, a rush of interim analyses from pharmaceutical companies Moderna and Pfizer/BioNTech have spurred optimism that a novel type of […]
It's the most optimistic scenario we have for vaccine development.
It's still just interim data, but it looks good.
Although it might take longer than that to approve the vaccine, its development has been extremely fast.
